South Africa’s regulators ordered an urgent recall of compounded GLP‑1 drugs by iDexis, warning prescribers of fines up to $4,600 and licence loss.
A daily Africa read from a Latin American newsroom. Free.
By subscribing you agree to our privacy policy. We never share your email.
AFRICA · SOUTHERN
Key Facts
—
JOHANNESBURG: South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its…
South Africa intensifies crackdown on illegal weight-loss drugs, seizing unregistered GLP-1 and GIP medicines amid safety…
South Africa's health regulators issue a stark warning to pharmacists and medical practitioners: continued use of recalled iDEXIS…
Local firm iDexis says it can guarantee quality and safety of its GLP-1 jabs
THE South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) have launched a…
South African regulators have recalled compounded Ozempic and Mounjaro copycat medicines, warning doctors and pharmacists of…
